PI
BBIO icon

PEAK6 Investments’s BridgeBio Pharma BBIO Stock Holding History

PEAK6 Investments’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.39M Buy
54,500
+37,000
+211% +$971K ﹤0.01% 1715
2024
Q2 		$443K Buy
17,500
+15,100
+629% +$413K ﹤0.01% 2316
2024
Q1 		$74.2K Buy
+2,400
New +$81.6K ﹤0.01% 3469
2023
Q4 		– Sell
-85,000
Closed -$2.24M – 4212
2023
Q3 		$2.24M Buy
+85,000
New +$2.41M 0.01% 1256
2021
Q1 		– Sell
-12,900
Closed -$917K – 4847
2020
Q4 		$917K Buy
+12,900
New +$622K ﹤0.01% 2557

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Investments's BBIO Position: Q3 2024 in Review

PEAK6 Investments sold out of BridgeBio Pharma (BBIO) in Q3 2024, closing a stake of 19,082 shares — an estimated $501K sold.

PEAK6 Investments first reported a position in BBIO in Q2 2022 and held it in 6 quarters. The position peaked at $740K in Q1 2024. 253 funds tracked by Wall St. Rank hold BBIO as of Q3 2024.

  • PEAK6 Investments reported no remaining BridgeBio Pharma position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 19,082 BridgeBio Pharma shares in Q3 2024, an estimated $501K.
  • PEAK6 Investments first reported a position in BridgeBio Pharma in Q2 2022 and held it in 6 quarters.
  • PEAK6 Investments's BridgeBio Pharma position peaked at $740K in Q1 2024.
  • 253 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.